Changes of Macrophage Migration Inhibitory Factor During Orthotopic Liver Transplantation
NCT02695979 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2018-03-01
Summary
Collecting blood, graft liver effluent and urine samples from patients undergoing orthotopic liver transplantation.
Conditions
- Evidence of Liver Transplantation
Sponsors & Collaborators
-
Medical University of Vienna
lead OTHER
Principal Investigators
-
Peter Faybik, Prof · Medical University Vienna, Department of Anesthesia, General Intensive Care and Pain Management
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-08-31
- Primary Completion
- 2018-09-30
- Completion
- 2019-08-31
Countries
- Austria
Study Locations
More Related Trials
-
Copeptin Serum Level in Liver Transplant Recipients
NCT03587623 ·Status: COMPLETED
-
Donor and Recipient Mismatch in Liver Transplantation
NCT07250919 ·Status: COMPLETED
-
Using Transcriptional Assessment of Immune Response to Assess Immunosuppression After Liver Transplantation
NCT06063213 ·Status: ACTIVE_NOT_RECRUITING
-
Single-center Prospective Study of Non-invasive Methods for the Diagnosis of Postoperative Complications in Liver Transplant Recipients
NCT05793203 ·Status: RECRUITING
-
LONGitudinal Multi-omics Phenotyping of KIDney Function Alteration
NCT05570929 ·Status: RECRUITING
-
Molecular Biological and Moleculargenetic Monitoring of Therapy After Kidney Transplantation
NCT01515605 ·Status: RECRUITING
-
Oxygen Dissociation Curve in Patients Undergoing Orthotopic Liver Transplantation
NCT05822570 ·Status: COMPLETED
-
Effects of Mannitol on Delayed Graft Function After Cadaveric Renal Transplantation
NCT02705573 ·Status: COMPLETED ·Phase: PHASE3
-
Machine Perfusion in High vs Low/Mid-volume Liver Transplant Centers: a Multicentre Survey
NCT05662969 ·Status: COMPLETED
-
Evolution and Clinical Outcomes in Patients Undergoing Liver Transplantation
NCT02917382 ·Status: UNKNOWN
-
The Regenerative Capacity of the Donor Liver After Living Donor Liver Transplantation: an Ambidirectional Cohort Study
NCT07329296 ·Status: ENROLLING_BY_INVITATION
-
Uses of Immunosuppression Therapy in Patients With Liver Transplantation
NCT01834690 ·Status: COMPLETED
-
Immunosuppression's Long Term Impact on Anti-tumoral Oversight in Kidney Transplantation
NCT03227965 ·Status: COMPLETED ·Phase: NA
-
Optimizing Long-term Survival in Organ Transplantation: From Physiopathology to Optimized Patient Management
NCT03997253 ·Status: RECRUITING ·Phase: NA
-
Immunometabolism of Machine Perfusion Strategies
NCT06371924 ·Status: RECRUITING ·Phase: NA
-
Persistent Lymphopenia in Liver Transplantation and Its Molecular Insights for Hepatocellular Carcinoma
NCT06368349 ·Status: COMPLETED
-
Assessing Declined Liver Grafts With Normothermic Machine Perfusion to Reduce Transplant Waiting Time
NCT06874296 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Kidney Disease in Liver Transplant Recipients
NCT00585429 ·Status: WITHDRAWN
-
Liver Transplantation: Skeletal Effects
NCT03399227 ·Status: WITHDRAWN
-
Serum GLYcomics to Predict Graft Loss and Mortality After Liver Transplantation
NCT05866796 ·Status: RECRUITING
-
ROTEM-based Optimization of Anticoagulation Regimens in Lung Transplantation
NCT06779162 ·Status: COMPLETED
-
The Role of Biomarkers in the Early Detection of Acute Kidney Injury Induced by Liver Transplantation
NCT01333319 ·Status: COMPLETED
-
A Retrospective Review of Infections Usually Observed in Transplant Recipients
NCT00298077 ·Status: COMPLETED
-
Liver Transplantation and Reticuloendothelial Clearance Capacity
NCT00929032 ·Status: COMPLETED
-
Impact of Level and Quality of Immunosuppression on Onset and Pattern of Cardiac Allograft Vasculopathy Evaluated by OCT
NCT03079791 ·Status: COMPLETED